ADMP logo

Adamis Pharmaceuticals (ADMP) Cash From Financing

Annual CFF

$285.00 K
-$53.65 M-99.47%

December 31, 2022

Summary

Performance

1-Year Change

-99.47%

3-Year Change

-97.68%

5-Year Change

-99.06%

15-Year Change

-99.06%

ADMP Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$53.94 M
ADMP annual cash flow from financing activities is currently -99.47% below its historical high of $53.94 million

3-Year Low

$285.00 K
ADMP annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ADMP previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
ADMP next annual earnings announcement has not yet been scheduled

OtherADMPcash flowmetrics:

Annual CFI

$3.48 M
ADMP annual cash flow from investing activities is $3.48 million

Annual CFO

-$25.90 M
ADMP annual cash flow from operations is -$25.90 million

Annual FCF

-$26.58 M
ADMP annual free cash flow is -$26.58 million

Annual CAPEX

$680.40 K
ADMP annual capital expenditures is $680.40 thousand

Quarterly CFF

$800.00
-$2.72 M-99.97%

June 30, 2023

Summary

Performance

3-Month Change

-99.97%

1-Year Change

+100%

3-Year Change

-99.97%

5-Year Change

+100.67%

ADMP Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$56.01 M
ADMP quarterly cash flow from financing activities is currently -100.00% below its historical high of $56.01 million

3-Year Low

-$42.80 K

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ADMP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ADMP next earnings announcement has not yet been scheduled

OtherADMPcash flowmetrics:

Quarterly CFI

$138.30 K
ADMP quarterly cash flow from investing activities is $138.30 thousand

Quarterly CFO

-$2.57 M
ADMP quarterly cash flow from operations is -$2.57 million

Quarterly FCF

-$2.57 M
ADMP quarterly free cash flow is -$2.57 million

Quarterly CAPEX

-
ADMP quarterly capital expenditures value is unknown

TTM CFF

$3.01 M
+$800.00+0.03%

June 30, 2023

Summary

Performance

3-Month Change

+0.03%

1-Year Change

+246.83%

3-Year Change

-86.29%

5-Year Change

-75.51%

ADMP TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$69.69 M
ADMP TTM cash flow from financing activities is currently -95.68% below its historical high of $69.69 million

3-Year Low

-$2.07 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ADMP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ADMP next earnings announcement has not yet been scheduled

OtherADMPcash flowmetrics:

TTM CFI

$1.91 M
ADMP TTM cash flow from investing activities is $1.91 million

TTM CFO

-$13.14 M
ADMP TTM cash flow from operations is -$13.14 million

TTM FCF

-$13.44 M
ADMP TTM free cash flow is -$13.44 million

TTM CAPEX

-
ADMP TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ADMP Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-99.5%+100.0%+246.8%
3 y3 years-97.7%-100.0%-86.3%
5 y5 years-99.1%+100.7%-75.5%

ADMP Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.5%at low-100.0%-5450.0%-94.4%-168.9%
5 y5-year-99.5%at low-100.0%<-9999.0%-95.7%-168.9%
alltimeall time-99.5%-1313.2%-100.0%<-9999.0%-95.7%-250.8%

Adamis Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2023
-
$800.00(-100.0%)
$3.01 M(+0.0%)
Mar 2023
-
$2.72 M(>+9900.0%)
$3.01 M(+955.9%)
Dec 2022
$285.00 K(-99.5%)
$0.00(-100.0%)
$285.00 K(+17.7%)
Sep 2022
-
$285.00 K(>+9900.0%)
$242.20 K(-111.8%)
Jun 2022
-
$0.00(0.0%)
-$2.05 M(-1.2%)
Mar 2022
-
$0.00(-100.0%)
-$2.07 M(-103.8%)
Dec 2021
$53.94 M(+171.1%)
-$42.80 K(-97.9%)
$53.94 M(+0.2%)
Sep 2021
-
-$2.01 M(+7994.0%)
$53.85 M(-19.0%)
Jun 2021
-
-$24.80 K(-100.0%)
$66.51 M(-4.6%)
Mar 2021
-
$56.01 M(<-9900.0%)
$69.69 M(+250.4%)
Dec 2020
$19.89 M(+61.8%)
-$128.70 K(-101.2%)
$19.89 M(-0.3%)
Sep 2020
-
$10.65 M(+236.8%)
$19.95 M(-9.1%)
Jun 2020
-
$3.16 M(-49.1%)
$21.95 M(+17.7%)
Mar 2020
-
$6.21 M(-8760.5%)
$18.64 M(+51.7%)
Dec 2019
$12.29 M(-66.9%)
-$71.70 K(-100.6%)
$12.29 M(+0.4%)
Sep 2019
-
$12.65 M(-8932.4%)
$12.24 M(-67.0%)
Jun 2019
-
-$143.20 K(+0.8%)
$37.09 M(-0.1%)
Mar 2019
-
-$142.00 K(+15.5%)
$37.11 M(-0.1%)
Dec 2018
$37.13 M(+21.9%)
-$122.90 K(-100.3%)
$37.13 M(+0.0%)
Sep 2018
-
$37.49 M(<-9900.0%)
$37.12 M(+132.6%)
Jun 2018
-
-$120.20 K(+0.4%)
$15.96 M(-47.6%)
Mar 2018
-
-$119.70 K(-9.8%)
$30.45 M(-0.0%)
Dec 2017
$30.46 M(+39.0%)
-$132.70 K(-100.8%)
$30.46 M(+0.6%)
Sep 2017
-
$16.33 M(+13.6%)
$30.27 M(+4.1%)
Jun 2017
-
$14.38 M(<-9900.0%)
$29.07 M(+73.2%)
Mar 2017
-
-$115.30 K(-64.5%)
$16.78 M(-23.4%)
Dec 2016
$21.91 M(+105.9%)
-$324.60 K(-102.1%)
$21.91 M(-1.5%)
Sep 2016
-
$15.13 M(+624.5%)
$22.24 M(+213.0%)
Jun 2016
-
$2.09 M(-58.4%)
$7.11 M(+41.6%)
Mar 2016
-
$5.02 M(>+9900.0%)
$5.02 M(-52.9%)
Dec 2015
$10.64 M(+122.5%)
$0.00(0.0%)
$10.64 M(0.0%)
Sep 2015
-
$0.00(0.0%)
$10.64 M(-32.2%)
Jun 2015
-
$0.00(-100.0%)
$15.70 M(+4.1%)
Mar 2015
-
$10.64 M(+110.2%)
$15.09 M(-29.9%)
Dec 2014
$4.78 M(-78.4%)
-
-
Sep 2014
-
$5.06 M(-918.8%)
$21.53 M(+30.7%)
Jun 2014
-
-$618.20 K(-120.1%)
$16.47 M(-25.7%)
Mar 2014
$22.18 M(+769.4%)
$3.07 M(-78.1%)
$22.18 M(+16.0%)
Dec 2013
-
$14.01 M(>+9900.0%)
$19.13 M(+234.6%)
Sep 2013
-
$8300.00(-99.8%)
$5.72 M(+0.1%)
Jun 2013
-
$5.09 M(>+9900.0%)
$5.71 M(+123.8%)
Mar 2013
$2.55 M(+20.7%)
$15.90 K(-97.4%)
$2.55 M(-20.0%)
Dec 2012
-
$600.00 K(>+9900.0%)
$3.19 M(-3.3%)
Sep 2012
-
$0.00(-100.0%)
$3.30 M(-25.0%)
Jun 2012
-
$1.94 M(+196.7%)
$4.40 M(+107.9%)
Mar 2012
$2.11 M(-58.6%)
$652.30 K(-7.8%)
$2.11 M(+52.6%)
Dec 2011
-
$707.20 K(-35.7%)
$1.39 M(-74.2%)
Sep 2011
-
$1.10 M(-418.8%)
$5.37 M(+12.8%)
Jun 2011
-
-$345.00 K(+349.8%)
$4.76 M(-6.8%)
Mar 2011
$5.11 M(+130.9%)
-$76.70 K(-101.6%)
$5.11 M(-23.4%)
Dec 2010
-
$4.69 M(+855.7%)
$6.67 M(+170.2%)
Sep 2010
-
$490.90 K(>+9900.0%)
$2.47 M(+21.9%)
Jun 2010
-
$0.00(-100.0%)
$2.02 M(-8.5%)
Mar 2010
$2.21 M
$1.49 M(+203.1%)
$2.21 M(+205.2%)
Dec 2009
-
$490.50 K(+950.3%)
$724.50 K(+209.6%)
DateAnnualQuarterlyTTM
Sep 2009
-
$46.70 K(-75.1%)
$234.00 K(+24.9%)
Jun 2009
-
$187.30 K(>+9900.0%)
$187.30 K(>+9900.0%)
Dec 2008
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2008
-
$0.00(-100.0%)
$0.00(0.0%)
Jun 2008
-
$500.00 K(-200.0%)
$0.00(-100.0%)
Mar 2008
-
-$500.00 K(<-9900.0%)
-$500.00 K(+1150.0%)
Dec 2007
-$40.00 K(-98.8%)
$0.00(0.0%)
-$40.00 K(-99.1%)
Sep 2007
-
$0.00(0.0%)
-$4.54 M(+38.0%)
Jun 2007
-
$0.00(-100.0%)
-$3.29 M(-3.7%)
Mar 2007
-
-$40.00 K(-99.1%)
-$3.41 M(-1.3%)
Dec 2006
-$3.46 M(-133.9%)
-$4.50 M(-459.7%)
-$3.46 M(-165.7%)
Sep 2006
-
$1.25 M(-1100.8%)
$5.26 M(+24.2%)
Jun 2006
-
-$125.00 K(+48.8%)
$4.24 M(-58.1%)
Mar 2006
-
-$84.00 K(-102.0%)
$10.11 M(-0.8%)
Dec 2005
$10.19 M(-11.1%)
$4.22 M(+1757.8%)
$10.19 M(+55.4%)
Sep 2005
-
$227.00 K(-96.1%)
$6.56 M(-60.9%)
Jun 2005
-
$5.75 M(>+9900.0%)
$16.78 M(+48.2%)
Mar 2005
-
$0.00(-100.0%)
$11.32 M(-1.2%)
Dec 2004
$11.46 M(+2082.4%)
$584.60 K(-94.4%)
$11.46 M(+4.9%)
Sep 2004
-
$10.45 M(+3528.5%)
$10.92 M(+2175.2%)
Jun 2004
-
$288.00 K(+113.3%)
$480.00 K(+147.4%)
Mar 2004
-
$135.00 K(+181.3%)
$194.00 K(-63.0%)
Dec 2003
$525.00 K(-91.3%)
$48.00 K(+433.3%)
$525.00 K(-91.9%)
Sep 2003
-
$9000.00(+350.0%)
$6.52 M(+28.9%)
Jun 2003
-
$2000.00(-99.6%)
$5.06 M(-10.0%)
Mar 2003
-
$466.00 K(-92.3%)
$5.62 M(-7.4%)
Dec 2002
$6.07 M(-58.4%)
$6.04 M(-515.8%)
$6.07 M(+6824.7%)
Sep 2002
-
-$1.45 M(-357.6%)
$87.60 K(-94.4%)
Jun 2002
-
$564.00 K(-38.3%)
$1.56 M(-89.9%)
Mar 2002
-
$914.00 K(+1360.1%)
$15.42 M(+5.8%)
Dec 2001
$14.57 M(+75.3%)
$62.60 K(+172.2%)
$14.57 M(-39.6%)
Sep 2001
-
$23.00 K(-99.8%)
$24.12 M(+3.3%)
Jun 2001
-
$14.42 M(>+9900.0%)
$23.34 M(+157.6%)
Mar 2001
-
$63.00 K(-99.3%)
$9.06 M(+9.0%)
Dec 2000
$8.31 M(-30.7%)
$9.62 M(-1370.3%)
$8.31 M(-1020.6%)
Sep 2000
-
-$757.00 K(-636.9%)
-$903.00 K(-108.9%)
Jun 2000
-
$141.00 K(-120.5%)
$10.14 M(-6.2%)
Mar 2000
-
-$687.00 K(-271.8%)
$10.81 M(-9.9%)
Dec 1999
$12.00 M(+242.9%)
$400.00 K(-96.1%)
$12.00 M(-17.2%)
Sep 1999
-
$10.29 M(+1167.0%)
$14.50 M(+214.4%)
Jun 1999
-
$812.00 K(+62.4%)
$4.61 M(+21.4%)
Mar 1999
-
$500.00 K(-82.8%)
$3.80 M(+8.6%)
Dec 1998
$3.50 M(-80.4%)
$2.90 M(+625.0%)
$3.50 M(-75.7%)
Sep 1998
-
$400.00 K(>+9900.0%)
$14.40 M(-20.0%)
Jun 1998
-
$0.00(-100.0%)
$18.00 M(-0.6%)
Mar 1998
-
$200.00 K(-98.6%)
$18.10 M(+1.1%)
Dec 1997
$17.90 M(+163.2%)
$13.80 M(+245.0%)
$17.90 M(+336.6%)
Sep 1997
-
$4.00 M(+3900.0%)
$4.10 M(+4000.0%)
Jun 1997
-
$100.00 K(>+9900.0%)
$100.00 K(-98.5%)
Mar 1997
-
$0.00(0.0%)
$6.80 M(0.0%)
Dec 1996
$6.80 M(+9.7%)
$0.00(0.0%)
$6.80 M(0.0%)
Sep 1996
-
$0.00(-100.0%)
$6.80 M(0.0%)
Jun 1996
-
$6.80 M(>+9900.0%)
$6.80 M(>+9900.0%)
Mar 1996
-
$0.00
$0.00
Dec 1995
$6.20 M
-
-

FAQ

  • What is Adamis Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals annual CFF year-on-year change?
  • What is Adamis Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals quarterly CFF year-on-year change?
  • What is Adamis Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals TTM CFF year-on-year change?

What is Adamis Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of ADMP is $285.00 K

What is the all time high annual CFF for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high annual cash flow from financing activities is $53.94 M

What is Adamis Pharmaceuticals annual CFF year-on-year change?

Over the past year, ADMP annual cash flow from financing activities has changed by -$53.65 M (-99.47%)

What is Adamis Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of ADMP is $800.00

What is the all time high quarterly CFF for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high quarterly cash flow from financing activities is $56.01 M

What is Adamis Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, ADMP quarterly cash flow from financing activities has changed by +$800.00 (+100.00%)

What is Adamis Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of ADMP is $3.01 M

What is the all time high TTM CFF for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high TTM cash flow from financing activities is $69.69 M

What is Adamis Pharmaceuticals TTM CFF year-on-year change?

Over the past year, ADMP TTM cash flow from financing activities has changed by +$5.06 M (+246.83%)